Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk and potential applications for addiction treatment.

Mounjaro weight loss jabs now available from GPs as NHS begins mass rollout - Around 29% of the adult population in the UK is obese ...

This story has been corrected as an earlier version said Wegovy AND Ozempic had been made available on prescription for ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

Both Wegovy and Ozempic are semaglutide – a drug that first entered the US market in 2017 as a diabetes medication. It was ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Weight loss injections are now available on the NHS but experts warn thousands of patients may be vulnerable to serious side ...

According to the CDC, 1 in 5 American adults is living with obesity. In recent years, many have turned to weight loss drugs ...